Colonial Trust Advisors’s Impact BioMedical IBO Stock Holding History
Bought
Maintained
Sold
Other funds holding IBO
Colonial Trust Advisors's IBO Position: Q3 2026 in Review
Colonial Trust Advisors opened a new position in Impact BioMedical (IBO) in Q3 2026: 7 shares worth $39. The stake represents ﹤0.01% of the portfolio and ranks #840 among its holdings.
19 funds tracked by Wall St. Rank hold IBO as of Q3 2026.
- Colonial Trust Advisors held 7 shares of Impact BioMedical worth $39 as of Q3 2026.
- Impact BioMedical was a new Colonial Trust Advisors position in Q3 2026.
- Impact BioMedical made up ﹤0.01% of Colonial Trust Advisors's portfolio in Q3 2026, its #840 holding.
- 19 funds tracked by Wall St. Rank held Impact BioMedical as of Q3 2026.
Based on Colonial Trust Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.